Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tradr 2X Short TSLA Daily ETF
TSLQ
5
ProShares UltraPro Short S&P500 ETF
SPXU
US Stock MarketDetailed Quotes
CGEN Compugen
- 1.400
- -0.040-2.78%
Close Apr 29 16:00 ET
- 1.420
- +0.020+1.43%
Post 19:00 ET
130.92MMarket Cap-8.75P/E (TTM)
1.450High1.400Low162.55KVolume1.450Open1.440Pre Close232.79KTurnover0.18%Turnover RatioLossP/E (Static)93.51MShares2.66052wk High2.39P/B128.24MFloat Cap1.13052wk Low--Dividend TTM91.60MShs Float19.900Historical High--Div YieldTTM3.47%Amplitude0.340Historical Low1.432Avg Price1Lot Size
About Compugen Company
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
Company Profile
SymbolCGEN
Company NameCompugen
Listing DateAug 11, 2000
Issue Price10.00
Founded1993
CEODr. Anat Cohen-Dayag, PhD
MarketNASDAQ
Employees74
Fiscal Year Ends12-31
AddressAzrieli Center,26 Harokmim Street,Building D
CityHolon
ProvinceTel Aviv
CountryIsrael
Zip Code58858
Phone972-3-765-8585
Websitehttp://www.cgen.com
Company Executives
- Name
- Position
- Salary
- Dr. Anat Cohen-Dayag, PhD
- Director, President and Chief Executive Officer
- 1.24M
- David Silberman
- Chief Financial Officer
- --
- Dr. Michelle Mahler, M.D.
- Chief Medical Officer
- 592.99K
- Dr. Eran Ophir, PhD
- Chief Scientific Officer
- 478.22K
- Dr. Zurit Levine,PhD
- Senior Vice President, Technology Innovation
- 461.80K
- Dr. Yaron Turpaz, PhD
- Senior Vice President and Senior Advisor, Computational Discovery
- --
- Dr. Pierre Ferre, Pd.D
- Senior Vice President, Preclinical Development and Corporate Operations
- 604.00K
- Paul J. Sekhri
- Chairman of the Board
- --
- Sanford S. Zweifach
- Independent Director
- --
- Gilead Halevy
- Independent Director
- --
- Eran Perry
- Independent Director
- --
- Dr. Mathias Hukkelhoven, PhD
- Independent Director
- --
- Dr. Kinneret Livnat Savitzky, PhD
- Independent Director
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now